tci Part B Insider - 2007 Issue 25
REIMBURSEMENT: OIG Wants To Squeeze Your Drug Payments Further
Doxorubic and Interferon are at the top of the hit listWarning: Your already low payments for Part B drugs could wind up slashed even further, if the HHS Office of Inspector General (OIG) gets its way. The OIG has been beating a drum on Part B drug payments for years, even after Medicare switched to a lowball system based on 106 percent of the Average Sales Price (ASP), or the manufacturer's regular price. In its latest report (OEI-03-07-00140), the OIG compared that amount with the amount wholesalers--who buy in bulk--pay for the drugs.Not surprisingly, the OIG found...
To read the full article, sign in and subscribe to tci Part B Insider.
Thank you for choosing Find-A-Code, please Sign In to remove ads.